Health-related quality of life in secondary progressive multiple sclerosis

Abstract

Common disability scales in multiple sclerosis (MS) are often weighted towards physical disability. Non-motor symptoms such as depression, fatigue and pain substantially influence wellbeing in MS. Health-related quality of life (HRQoL) measures the broader impact of MS and might indicate less obvious disease burdens. We analysed HRQoL, using the Nottingham Health Profile Part I (NHP-I), among 345 secondary progressive MS (SPMS) patients participating in a randomized trial of interferon-β1a (IFN-β1a), 22 μg subcutaneously weekly, or matching placebo. The results did not reveal any beneficial effect of IFN-β1a in any outcome measure. NHP-I sub- and sum scores were compared for 217 population controls and correlated with demographic and clinical disease variables. SPMS patients had lower NHP-I sum and all subscores than the controls. Patients experiencing disease progression reported worse NHP-I sum scores. Increased fatigue, Expanded Disability Status Scale (EDSS) and Arm Index scores were independently associated with reduction in several NHP-I subscores. SPMS patients had significantly lower HRQoL than controls and physical disability (EDSS and Arm Index), disease progression and fatigue strongly influenced this. MS

Keywords

fatigue multiple sclerosis quality of life

Get full access to this article

View all access options for this article.

References

Weinshenker BG The natural history ofl multiple sclerosis . Neurol Clin 1995; 13: 119-46 .

SPECTRIMS Study Group. Randomized controlled trial ofl interfleron-beta-1a in secondary progressive MS: clinical results . Neurology 2001; 56: 1496-504 .

Benito-Leon J. , Morales JM , Rivera-Navarros J. , Mitchell AJ A review about the impact ofl multiple sclerosis on health-related quality ofl lifle . Disabil Rehabil 2003; 25: 1291-303 .

Fruehwald S. , Loeffler-Stastka H. , Eher R. , Saletu B. , Baumhackl U. Depression and quality ofl lifle in multiple sclerosis . Acta Neurol Scand 2001; 104: 257-61 .

Benedict Rhb , Wahlig E. , Bakshi R. , Fishman I. , Munschauer F. , Zivadinov R. et al. Predicting quality ofl lifle in multiple sclerosis: accounting flor physical disability, flatigue, cognition, mood disorder, personality, and behaviour change . J Neurol Sci 2005; 231: 29-34 .

Mitchell AJ , Benito-Leon J. , Gonzales J-MM , Rivera-Navarro J. Quality ofl lifle and its assessment in multiple sclerosis: integrating physical and psychological components ofl wellbeing . Lancet Neurol 2005; 4: 556-66 .

Merkelbach S. , Sittinger H. , Koenig J.

Is there a diflflerential impact ofl flatigue and physical disability on quality ofl lifle in multiple sclerosis?

J Nerv Ment Dis 2002; 190: 388-93 .

Weinshenker BG , Penman M. , Bass B. , Ebers GC , Rice Gpa. A double-blind, randomized crossover trial ofl pemoline in flatigue associated with multiple sclerosis . Neurology 1992; 42: 1468-71 .

Freal JE , Kraft GH , Coryell JK Symptomatic flatigue in multiple sclerosis . Arch Phys Med Rehabil 1984; 65: 135-38 .

10.

Fisk J. , Ritvo PG , Ross L. , Haase DA , Marrie TJ , Schlech WF Measuring the flunctional impact ofl flatigue: initial validation ofl the Fatigue Impact Scale . Clin Inf Dis 1994; 18: 79-83 .

11.

Beiske A. , Pedersen ED , Czujko B. , Myhr K-M. Pain and sensory complaints in multiple sclerosis . Eur J Neurol 2004; 11: 479-82 .

12.

Nortvedt MW , Riise T. , Myhr KM , Nyland HI Quality ofl lifle as a predictor flor change in disability in MS . Neurology 2000; 55: 51-54 .

13.

Visschedijk Maj , Uitdehaag Mbj , Klein M. , van der Ploeg E. , Collette EH , Vleugels L. et al. Value ofl healthrelated quality ofl lifle to predict disability course in multiple sclerosis . Neurology 2004; 63: 2046-50 .

14.

Freeman JA , Thompson AJ , Fitzpatrick R. , Hutchinson M. , Miltenburger C. , Beckmann K. et al. Interfleron-beta 1b in the treatment ofl secondary progressive MS. Impact on quality ofl lifle . Neurology 2001; 57: 1870-75 .

15.

Cohen JA , Cutter GR , Fischer JS , Goodman Ad , Heidenreich FR , Kooijmans MF et al. Benefit ofl interfleron beta-1a on MSFC progression in secondary progressive MS . Neurology 2002; 59: 679-87 .

16.

Hunt SM , McKenna SP , McEwen J. , Williams J. , Papp E. The Nottingham Health Profile: subjective health status and medical consultations . Soc Sci Med 1981; 15A: 221-29 .

17.

Jenkinson C. , Fitzpatrick R. , Argyle M. The Nottingham Health Profile: an analysis ofl its sensitivity in diflflerentiating illness groups . Soc Sci Med 1998; 27: 1411-14 .

18.

Andersen O. , Elovaara I. , Farkkila M. , Hansen HJ , Mellgren, Myhr KM et al. Multicentre, randomised, double blind, placebo controlled, phase III study ofl weekly, low dose, subcutaneous interfleron beta-1a in secondary progressive multiple sclerosis . J Neurol NeurosurgPsychiatry 2004; 75: 706-10 .

19.

Poser CM , Paty DW , Scheinberg L. , McDonald I. , Davis FA , Ebers GC et al. New diagnostic criteria flor multiple sclerosis: guidelines flor research protocols . Ann Neurol 1983; 13: 227-31 .

20.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 1983; 33: 1444-52 .

21.

Barnes D. , Hughes Rac , Morris RW , Wade-Jones O. , Brown P. , Britton T. et al. Randomised trial ofl oral and intravenous methylprednisolone in acute relapses ofl multiple sclerosis . Lancet 1997; 349: 902-906 .

22.

Weiner HL , Mackin GA , Orav EJ , Hafler DA , Dawson DM , LaPierre Y. et al. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report ofl the Northeast Cooperative Multiple Sclerosis Treatment Group . Neurology 1993; 43: 910-18 .

23.

Grant S. , Aitchison T. , Henderson E. , Christie J. , Zare S. , McMurray J. et al. A comparison ofl the reproducibility and the sensitivity to change ofl visual analog scales, Borg scales, and Likert scales in normal subjects during submaximal exercise . Chest 2001; 116: 1208-17 .

24.

Hunt SM , Wicklund I. Cross-cultural variation in the weighting ofl health statements: a comparison ofl English and Swedish valuations . Health Policy 1987; 8: 227-35 .

25.

Wicklund I. , Romanus B. , Hunt SM Selfl-assessed disability in patients with arthrosis ofl the hip joint. Reliability ofl the Swedish version ofl the Nottingham Health Profile . Int Disabil Stud 1988; 10: 159-63 .

26.

Nortvedt MW , Riise T. , Myhr K-M. , Nyland HI Quality ofl lifle in multiple sclerosis. Measuring the disease eflflects more broadly . Neurology 1999; 53: 1098-103 .

27.

Canadian Burden of Illness Study Group. Burden ofl illness ofl multiple sclerosis. Part II: Quality ofl lifle . Can J Neurol Sci 1998; 25: 31-38 .

28.

Murphy N. , Confavreaux C. , Haas J. , König N. , Roullet E. , Sailer M. et al. Quality ofl lifle in multiple sclerosis in France, Germany, and the United Kingdom . J Neurol Neurosurg Psychiatry 1998; 65: 460-66 .

29.

Schwartz L. , Kraft GH The role ofl spouse responses to disability and flamily environment in multiple sclerosis . Am J Phys Med Rehabil 1999; 78: 525-32 .

30.

Solari A. , Palmisano L. , Mendozzi L. , Ghezzi A. , Mosconi P. , Pozzilli C. The impact ofl multiple sclerosis on health-related quality ofl lifle . Neurology 1999; 52: A141 .

31.

Nicholl CR , Lincoln NB , Francis VM , Stephan TF Assessing quality ofl lifle in people with multiple sclerosis . Disabil Rehabil 2001; 23: 597-603 .

32.

Rotstein Z. , Barak Y. , Noy S. , Achiron A. Quality ofl lifle in multiple sclerosis: development and validation ofl the ``RAYS'' scale and comparison with the SF-36 . Int J Qual Health Care 2000; 12: 511-17 .

33.

McCabe MP , McKern S. Quality ofl lifle and multiple sclerosis: comparison between people with multiple sclerosis and people flrom the general population . J Clin Psychol 2002; 9: 287-95 .

34.

Janssens Acjw , van Dorn PA , de Boer JB , van der Meché Fga , Passchier J. , Hintzen RQ Impact ofl recently diagnosed multiple sclerosis on quality ofl lifle, anxiety, depression and distress ofl patients and partners . Acta Neurol Scand 2003; 108: 389-95 .

35.

Patti F. , Cacopardo M. , Palermo F. , Ciancio MR , Lopes R. , Restivo D. et al. Health-related quality ofl lifle and depression in an Italian sample ofl multiple sclerosis patients . J Neurol Sci 2003; 211: 55-62 .

36.

Isaksson AK , Ahlstrøm G. , Gunnarsson LG Quality ofl lifle and impairment in patients with multiple sclerosis . J Neurol Neurosurg Psychiatry 2005; 76: 64-69 .

37.

Freeman JA , Langdon DW , Hobart JC , Thompson AJ

Inpatient rehabilitation in multiple sclerosis. Do the benefits carry over into the community?

Neurology 1999; 52: 50-56 .

38.

Rudick RA , Miller D. , Clough JD , Gragg LA , Farmer G. Quality ofl lifle in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis . Arch Neurol 1992; 49: 1237-42 .

39.

Sprangers Mag , de Regt EB , Andries F. , van Agt Hme , Bijl RV , de Boer JB et al. Which chronic conditions are associated with better or poorer quality ofl lifle ? J Clin Epidemiol 2000; 53: 895-907 .

40.

Pfennings L. , Cohen L. , Herman A. , Polman C. , Lankhorst G. , Smits R. et al. Exploring diflflerences between subgroups ofl multiple sclerosis patients in health-related quality ofl lifle . J Neurol 1999; 246: 587-91 .

41.

Shawaryn MA , Schiaffino KM , LaRocca NG , Johnston MV Determinants ofl health-related quality ofl lifle in multiple sclerosis: the role ofl illness intrusiveness . Mult Scler 2002; 8: 310-18 .

42.

Zivadinov R. , Zorzon M. , Tommasi MA , Nasuelli D. , Bernardi M. , Monti-Bragadin L. et al. A longitudinal study ofl quality ofl lifle and side eflflects in patients with multiple sclerosis treated with interfleron beta-1a . J Neurol Sci 2003; 216: 113-18 .

43.

Janardhan V. , Bakshi R. Quality ofl lifle in patients with multiple sclerosis: the impact ofl flatigue and depression . J Neurol Sci 2002; 205: 51-58 .

44.

Loge JH , Kaasa S. Short Form (SF-36) health survey: normative data flrom the general Norwegian population . Scand J Soc Med 1998; 26: 250-58 .

45.

Sullivan M. , Karlsson J. The Swedish SF-36 Health Survey-III. Evaluation ofl criterion-based validity: results flrom normative population . J Clin Epidemiol 1998; 51: 1105-13 .

46.

Moulin DE , Foley KM , Ebers GC Pain syndromes in multiple sclerosis . Neurology 1998; 38: 1830-34 .

47.

Stenager E. , Knutsen L. , Jensen K. Acute and chronic pain syndromes in multiple sclerosis . Acta Neurol Scand 1991; 84: 197-200 .

48.

Pittock SJ , Mayr WT , McClelland RL , Jorgens NW , Weigand SD , Noseworthy JH et al. Quality ofl lifle is flavourable flor most patients with multiple sclerosis . Arch Neurol 2004; 61: 679-86 .

49.

Murray TJ The psychosocial aspects ofl multiple sclerosis . Neurol Clin 1995; 13: 197- 223 .

50.

Ford HL , Gerry E. , Johnson MH , Tennant A. Health status and quality ofl lifle ofl people with multiple sclerosis . Disabil Rehabil 2001; 23: 516-21 .

51.

Katschnig H. How useflul is the concept ofl quality ofl lifle in psychiatry ? Curr Opin Psychiatry 1997; 10: 337-45 .

52.

Tachibana N. , Howard RS , Hirsch NP , Miller DH , Moseley IF , Fish D. Sleep problems in multiple sclerosis . Eur J Neurol 1994; 34: 320-23 .

53.

Fleming WE , Pollak CP Sleep disorders in multiple sclerosis . Semin Neurol 2005; 25: 64-68 .

54.

Pakenham KI Adjustment to multiple sclerosis: application ofl a stress and coping model . Health Psychol 1999; 18: 383-92 .

55.

Vickrey BG , Hays RD , Harooni R. , Myers LW , Ellison GW A health-related quality ofl lifle measure flor multiple sclerosis . Qual Life Res 1995; 4: 187-206 .

56.

Vermersch P. , de Seze J. , Delisse B. , Lemaire S. , Stojkovic T. Quality ofl lifle in multiple sclerosis: influence ofl interfleron-beta 1a (Avonex) treatment . Mult Scler 2002; 8: 377-81 .

57.

Gruenewald DA , Higginson IJ , Vivat B. , Edmonds P. , Burman RE Quality ofl lifle measures flor the palliative care ofl people severely aflflected by multiple sclerosis: a systematic review . MultScler 2001; 10: 690-704 .

58.

Rothwell PM , McDowell Z. , Wong CK , Dorman PJ Doctors and patients don't agree: cross sectional study ofl patients' and doctors' perceptions and assessments ofl disability in multiple sclerosis . BMJ 1997; 314: 1580-83 .

59.

Gold SM , Schulz H. , Mønch A. , Schulz K-H. , Heesen C. Cognitive impairment in multiple sclerosis does not aflflect reliability and validity ofl selfl-report health measures . Mult Scler 2001; 9: 404-10 .

60.

Marrie RA , Miller DM , Chelune GJ , Cohen JA Validity and reliability ofl the MSQLI in cognitively impaired patients with multiple sclerosis . Mult Scler 2003; 9: 621-26 .

61.

Moore F. , Wolfson C. , Alexandrov L. , Lapierre Y. Do general and multiple sclerosis-specific quality ofl lifle instruments diflfler ? Can J Neurol Sci 2004; 31: 64-71 .

62.

Stolee P. , Zaza C. , Pedlar A. , Myers AM An individualised approach to outcome measurement in geriatric rehabilitation . J Gerontol Ser A Bio Sci Med Sci 1999; 54: 641-47 .

63.

LaChapelle Dl , Finlayson MA An evaluation ofl subjective and objective measures ofl flatigue in patients with brain injury and healthy controls . Brain Inj 1998; 12: 649-59 .